In response to a measles outbreak and statewide emergency in New York, CVS Health is offering measles-mumps-rubella (MMR) vaccinations at over 530 CVS Pharmacy locations and MinuteClinic sites across the state. The MMR vaccine is crucial to prevent the highly contagious measles virus, which can spread before symptoms appear. Eligible patients aged 3 and older can receive the vaccine, with MinuteClinic providing the recommended second dose for children aged 4 to 6. CVS encourages New Yorkers to ensure their vaccinations are up to date and to schedule appointments online for convenience and availability.
CVS Health shares are trading at USD 86.95 as of Oct 07, 2026 19:12 WIB on Pluang, up 0.60% for the day but still well below their 52-week high of USD 110.60. The stock's 52-week low is USD 70.08, showing a significant range in price movement over the past year. Despite the positive daily change, Pluang users are currently 100% selling CVS shares, reflecting cautious sentiment even as the company supports public health efforts during the New York measles outbreak.
CVS Health announced it will hold a conference call on November 4, 2026, to discuss its third quarter financial results. The event will be webcast live on the company's investor relations website and archived for one year. CVS Health operates around ...
Aetna, part of CVS Health, announced its 2027 Medicare offerings featuring $0 copays on Tier 1 drugs, vaccines, and key preventive services like annual physicals and screenings. The plans expand Chronic Condition Special Needs Plans to 25 states and ...
